156 related articles for article (PubMed ID: 24997147)
1. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.
Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A
Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147
[No Abstract] [Full Text] [Related]
2. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
[TBL] [Abstract][Full Text] [Related]
3. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
4. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
5. IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
Granai M; Amato T; Di Napoli A; Santi R; Vergoni F; Di Stefano G; Mancini V; Kovalchuk S; Cencini E; Carta AG; Aversa S; Ziepert M; Cevenini G; Lazzi S; Leoncini L; Bellan C
Virchows Arch; 2020 Jul; 477(1):143-150. PubMed ID: 31802229
[TBL] [Abstract][Full Text] [Related]
6. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
[No Abstract] [Full Text] [Related]
7. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
8. Somatic hypermutation of immunoglobulin heavy chain variable region genes in thymic marginal zone B-cell lymphoma of MALT type of a patient with Sjögren's syndrome.
Kamimura K; Nakamura N; Ishibashi T; Maruyama Y; Abe M
Histopathology; 2002 Mar; 40(3):294-6. PubMed ID: 11895498
[No Abstract] [Full Text] [Related]
9. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
[TBL] [Abstract][Full Text] [Related]
11. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.
Hockley SL; Giannouli S; Morilla A; Wotherspoon A; Morgan GJ; Matutes E; Gonzalez D
Br J Haematol; 2010 Feb; 148(4):666-9. PubMed ID: 19863540
[No Abstract] [Full Text] [Related]
12. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
13. Analysis of VH genes in 49 marginal zone lymphoma cases reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
Dewolf Peeters C
Haematologica; 2005 Apr; 90(4):435. PubMed ID: 15820929
[No Abstract] [Full Text] [Related]
14. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
[TBL] [Abstract][Full Text] [Related]
15. A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: ontogenetic implications.
Papadaki T; Stamatopoulos K; Mavrommatis T; Anagnostopoulos A; Anagnostou D
Leuk Res; 2008 Jan; 32(1):155-7. PubMed ID: 17420049
[TBL] [Abstract][Full Text] [Related]
16. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.
Bikos V; Stalika E; Baliakas P; Darzentas N; Davis Z; Traverse-Glehen A; Dagklis A; Kanellis G; Anagnostopoulos A; Tsaftaris A; Ponzoni M; Berger F; Felman P; Ghia P; Papadaki T; Oscier D; Belessi C; Stamatopoulos K
Leukemia; 2012 Dec; 26(12):2567-9. PubMed ID: 22858907
[No Abstract] [Full Text] [Related]
17. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.
Stamatopoulos K; Belessi C; Papadaki T; Kalagiakou E; Stavroyianni N; Douka V; Afendaki S; Saloum R; Parasi A; Anagnostou D; Laoutaris N; Fassas A; Anagnostopoulos A
Mol Med; 2004; 10(7-12):89-95. PubMed ID: 15706403
[TBL] [Abstract][Full Text] [Related]
18. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine.
Scapinello G; Pizzi M; Vio S; Nabergoj M; Visentin A; Martines A; Bonaldi L; Trentin L; Semenzato G; Piazza F
Ann Hematol; 2018 Oct; 97(10):2001-2003. PubMed ID: 29728736
[No Abstract] [Full Text] [Related]
19. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
[TBL] [Abstract][Full Text] [Related]
20. Rare occurrence of IgVH gene translocations and restricted IgVH gene repertoire in ocular MALT-type lymphoma.
Adam P; Haralambieva E; Hartmann M; Mao Z; Ott G; Rosenwald A
Haematologica; 2008 Feb; 93(2):319-20. PubMed ID: 18245662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
